Cajeta, Arian .

HRN: 22-34-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2022
CEFTRIAXONE 1G (VIAL)
12/23/2022
12/29/2022
IVT
680mg
Q12
Periapical Abscess
Waiting Final Action 
12/23/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/23/2022
12/29/2022
IVT
140mg
Q8
Periapical Abscess
Waiting Final Action 
12/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/24/2022
12/31/2022
IV
1.2 G
Q6
Periapical Abscess On Molar Tooth (Lower Jaw) Right
Waiting Final Action 
01/01/2023
MUPIROCIN 2%, 15G (TUBE)
01/01/2023
01/07/2023
TOPICAL
2%
BID
Infiltrated Post IV Site
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: